Skip to main content

Table 2 Clinical and biochemical characteristics of an independent set of male and female subjects

From: Gene expression profiling of subcutaneous adipose tissue in morbid obesity using a focused microarray: Distinct expression of cell-cycle- and differentiation-related genes

 

Females (n = 41)

Males (n = 17)

 

Patients (n = 31)

Controls (n = 10)

Patients (n = 9)

Controls (n = 8)

Current smokers, n (%)

13 (41.9)

0 (0)*

4 (44.4)

1 (12.5)*

Age (years)

36.4 ± 10.3

49.6 ± 14.9*

37.0 ± 12.6

51.3 ± 12.4*

Body mass index (kg/m2)

49.5 ± 7.3

23.4 ± 3.1*

49.3 ± 7.2

23.9 ± 1.6*

Systolic blood pressure (mmHg)

128.1 ± 13.6

121.1 ± 11.7

131.3 ± 11.3

128.0 ± 8.2

Diastolic blood pressure (mmHg)

76.7 ± 9.7

66.7 ± 9.7*

83.1 ± 13.3

62.0 ± 3.8*

Mean blood pressure (mmHg)

84.7 ± 29.7

84.8 ± 9.7

88.1 ± 34.8

73.5 ± 30.1*

Serum creatinine (mg/dL)

0.79 ± 0.10†

0.76 ± 0.10†

1.15 ± 0.38

1.02 ± 0.13

Aspartate aminotransferase (U/L)

22.7 ± 9.9

17.1 ± 2.0

34.0 ± 28.0

19.2 ± 3.1

Alanine aminotransferase (U/L)

36.6 ± 32.8

14.6 ± 5.5*

61.3 ± 54.4

16.5 ± 2.8*

Fasting glucose (mg/dL)

99.5 ± 29.5

96.7 ± 8.9

120.6 ± 89.6

98.3 ± 10.7

Cholesterol (mg/dL)

190.8 ± 36.8

204.8 ± 39.9

199.6 ± 34.1

195.0 ± 19.3

Triglycerides (mg/dL)

118.1 ± 52.8

66.0 ± 20.9*

175.8 ± 99.3

104.1 ± 62.3

  1. Data are means ± SD unless otherwise stated.
  2. *P < 0.05 between patients and controls analyzed by Mann-Whitney U test for pair analysis after significant Kruskal Wallis test.
  3. †P < 0.05 between females and males analyzed by Mann-Whitney U test for pair analysis after significant Kruskal Wallis test.